Liminal Biosciences Inc. (LMNL) Social Stream



Liminal Biosciences Inc. (LMNL): $0.55

0.04 (+8.91%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add LMNL to Watchlist
Sign Up

Industry: Biotech


Ranked

of 503

in industry

Liminal BioSciences Inc (LMNL) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering LMNL.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-08-17 4 $4.5 $2.3 $3.1 $0.97 219.59%
2022-03-21 2 $2.3 $2 $2.15 $0.97 121.65%

The Trend in the Analyst Price Target


LMNL's average price target has moved down $0.62 over the prior 26 weeks.

Over the past 48 weeks, LMNL's average upside potential has been 86.67%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-25 2 22.03809 2.70468 9.94036 4.00 148.51%
2021-05-27 4 21.15995 2.69308 9.56980 4.23 126.24%
2021-05-27 4 22.09544 2.81215 9.99288 4.23 136.24%
2021-07-29 4 4.47770 2.28860 3.58318 2.94 21.88%
2021-07-29 4 4.51771 2.30905 3.61519 2.94 22.97%

LMNL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 0 0 2 0 0 2

The Trend in the Broker Recommendations


LMNL's average broker recommendation rating improved by 0 over the prior 30 weeks.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for LMNL as an investment opportunity.

  • Liminal BioSciences Inc's average analyst price target is greater than 4.07% of all US stocks.
  • LMNL has a higher number of analysts covering the stock than 46.07% of all US stocks.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, Liminal BioSciences Inc's variance in analysts' estimates is lower than -173.85% of them.
  • In the context of stocks in the small market cap category, Liminal BioSciences Inc's upside potential (average analyst target price relative to current price) is greater than 274.39% of them.

In the Pharmaceutical Products industry, LIAN, LGVN, and LFVN are the three stocks most similar to Liminal BioSciences Inc regarding the price target and analyst recommendation information presented here.

Is LMNL a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.3694 seconds.